10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Genmab A/S (GMAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,786,428 | $43,553,115 | +23% | 0.06% |
| 2. | Orbis Investment Management William B. Gray | 1,676,793 | $40,880,214 | 0.21% | |
| 3. | Citadel Investment Group Ken Griffin | 1,299,856 | $31,690,489 | +3% | 0% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 615,100 | $14,996,138 | +85% | 0.03% |
| 5. | Millennium Management Israel Englander | 564,832 | $13,770,604 | +49% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,614,510 | $497,165,998 | 0.19% | |
| 2. | 4,409,575 | $140,400,861 | 0% | |
| 3. | 4,057,922 | $129,650,575 | 0.02% | |
| 4. | 3,289,895 | $97,568,587 | 0.54% | |
| 5. | 2,369,331 | $75,439,498 | 0.01% |
News See All
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Genmab A/S (NASDAQ:GMAB) Q3 2024 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Financial Results Conference Call for the First Nine Months of 2024. As a reminder, this conference call is being recorded.
12 Most Profitable Growth Stocks To Invest In
After the September inflation report, the market did feel a slight bit of panic but it seems to be fading away.
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
7 Best Revenue Growth Stocks to Buy According to Analysts
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms.
10 Best Affordable Stocks Under $40 According to Short Sellers
Several traders tend to profit from stocks through appreciation. However, some do the opposite-- their idea is to profit from stocks when their value declines.
Genmab A/S (NASDAQ:GMAB) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab First Half 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Billionaire Hedge Funds
